Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD trial

Autor: Stefan G. Spitzer, Neil C. Davidson, Marcus Wieczorek, Zoltán Csanádi, Steve Furniss, Mélèze Hocini, Lukas R.C. Dekker, J. Christoph Geller, Lucas V.A. Boersma, Stephen Murray, Yves De Greef
Přispěvatelé: Other departments, Signal Processing Systems, Biomedical Diagnostics Lab
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
medicine.medical_treatment
International Cooperation
PVAC GOLD
Ablation
030204 cardiovascular system & hematology
Pulmonary vein
0302 clinical medicine
Atrial Fibrillation
030212 general & internal medicine
Prospective Studies
Prospective cohort study
medicine.diagnostic_test
Incidence
Atrial fibrillation
Orvostudományok
Equipment Design
Middle Aged
Magnetic Resonance Imaging
Electrodes
Implanted

Europe
Catheter
Treatment Outcome
Intracranial Embolism
Pulmonary Veins
Catheter Ablation
Female
Radiology
medicine.symptom
Cardiology and Cardiovascular Medicine
medicine.medical_specialty
Catheter ablation
Klinikai orvostudományok
Pulmonary vein isolation
Asymptomatic
03 medical and health sciences
Physiology (medical)
medicine
Humans
Aged
Platinum
business.industry
Asymptomatic cerebral embolism
Magnetic resonance imaging
medicine.disease
Logistic Models
Linear Models
Gold
Nuclear medicine
business
Zdroj: Europace : European pacing, arrhythmias, and cardiac electrophysiology, 18(5), 687-695. Oxford University Press
Europace, 18(5), 687-695. Oxford University Press
ISSN: 1099-5129
Popis: Aims This prospective, multicentre study (PRECISION GOLD) evaluated the incidence of asymptomatic cerebral embolism (ACE) after pulmonary vein isolation (PVI) using a new gold multi-electrode radiofrequency (RF) ablation catheter, pulmonary vein ablation catheter (PVAC) GOLD. Also, procedural efficiency of PVAC GOLD was compared with ERACE. The ERACE study demonstrated that a low incidence of ACE can be achieved with a platinum multi-electrode RF catheter (PVAC) combined with procedural manoeuvres to reduce emboli. Methods and results A total of 51 patients with paroxysmal atrial fibrillation (AF) (age 57 ± 9 years, CHA2DS2-VASc score 1.4 ± 1.4) underwent AF ablation with PVAC GOLD. Continuous oral anticoagulation using vitamin K antagonists, submerged catheter introduction, and heparinization (ACT ≥ 350 s prior to ablation) were applied. Cerebral magnetic resonance imaging (MRI) scans were performed within 48 h before and 16–72 h post-ablation. Cognitive function assessed by the Mini-Mental State Exam at baseline and 30 days post-ablation. New post-procedural ACE occurred in only 1 of 48 patients (2.1%) and was not detectable on MRI after 30 days. The average number of RF applications per patient to achieve PVI was lower in PRECISION GOLD (20.3 ± 10.0) than in ERACE (28.8 ± 16.1; P = 0.001). Further, PVAC GOLD ablations resulted in significantly fewer low-power (
Databáze: OpenAIRE